Last updated: May 16, 2026
This page documents the editorial principles that govern content production at HealthDataConsortium.org. It complements the Methodology & Disclosures page, which covers analytical frameworks and financial disclosures. The standards described below apply to every analysis published on this site.
Source Verification Protocol
Before any analysis is published, every factual claim is traced to a verifiable source. Sources are documented internally and cited within the analysis. The verification process includes the following steps:
Primary source identification. Claims about clinical effects are traced to the original peer-reviewed study, not to a secondary article reporting on the study. Claims about product formulations are traced to the manufacturer's published Supplement Facts panel or prescribing information, not to marketing copy. Claims about regulatory status are traced to the relevant FDA, FTC, or state regulatory database.
Source quality assessment. Each source is evaluated for relevance, methodological rigor, and currency. Animal studies are not extrapolated to human effects without explicit qualification. In vitro studies are not presented as evidence of in vivo activity. Preliminary findings are not described as established science.
Citation specificity. Studies are cited with sufficient detail for readers to locate them independently — typically first author, year, and journal name, with DOI or PubMed identifier where available. Phrases such as “studies show” or “research suggests” without specific citation are not used.
Currency verification. Pricing, platform terms, regulatory status, and product formulations are verified by direct fetch of the relevant source within a defined window before publication. The “Last verified” date noted on any analysis reflects an actual verification, not a cosmetic update.
Evidence Classification
Analyses distinguish between the following evidence categories, and language is calibrated to each:
Established evidence refers to claims supported by multiple high-quality clinical trials in human populations, ideally with consistent findings across studies and inclusion in clinical practice guidelines. Language: “research demonstrates,” “clinical evidence supports.”
Emerging evidence refers to claims supported by limited human trials, single studies awaiting replication, or surrogate endpoint data. Language: “preliminary research suggests,” “early-stage studies indicate,” “is associated with in available trials.”
Mechanistic or preclinical evidence refers to claims supported by laboratory studies, animal models, or in vitro findings without confirmed human application. Language: “mechanistic studies suggest,” “in animal models,” “the proposed mechanism is.”
Marketing claims refer to assertions made by manufacturers or platforms without independent verification. Language: “the manufacturer states,” “platform marketing describes,” “is claimed to.”
Mixing these categories — for example, presenting mechanistic findings as established evidence of human benefit — is a violation of these standards and grounds for content revision.
Anti-Fabrication Principles
The following are categorically prohibited in any content published on this site:
- Invented studies, citations, or research findings
- Fabricated statistics, percentages, or quantitative claims
- Invented customer testimonials or outcome stories
- Attributed physician endorsements without verified, named, sourced attribution
- Fabricated FDA approvals, clearances, certifications, or third-party testing results
- Invented product specifications, ingredient amounts, or formulation details
- Misrepresentation of study findings to imply support the source does not provide
If a claim cannot be verified, it is either rewritten in qualified language, marked explicitly as unverified, or removed from the analysis.
What This Publication Does Not Do
Disease claims. No supplement covered on this site is described as preventing, treating, curing, or diagnosing a disease. This is both a regulatory requirement under the Dietary Supplement Health and Education Act and a principled boundary. Supplements are evaluated for evidence supporting structure or function effects, not for disease intervention.
Absolute efficacy claims. Language such as “will,” “proven to,” “guaranteed to,” or definitive outcome predictions is not used in supplement or health content. Evidence-qualified language is the standard.
Star ratings, X out of 10 scores, or aggregate review scores. These devices imply a standardized scoring rigor that this publication does not claim. The publication's evaluation frameworks are documented, but they do not produce a single quantitative score against which products are ranked. Analyses identify which categories of reader a product or platform serves well, not which product is universally “best.”
Endorsements in exchange for payment. No manufacturer, platform, or brand has editorial review rights, pre-publication access, veto authority, or paid-placement positioning in any analysis. Paid link relationships exist only as post-purchase commissions on links the reader chooses to click, and these relationships are disclosed.
Anonymous YMYL authorship without editorial accountability. All content published on this site is produced under the HDC Health Intelligence Desk editorial entity, with a documented methodology available on the Methodology & Disclosures page and the editorial principles documented on this page. Readers who wish to evaluate the credibility of any analysis can review the underlying methodology and the source citations within the analysis.
Conflicts of Interest
The publication's only financial relationship with the products and platforms it analyzes is the paid link commission model documented on the Methodology & Disclosures page. The publication does not:
- Accept payment from manufacturers for favorable analysis
- Accept free product in exchange for guaranteed coverage
- Grant editorial review or approval rights to companies whose products are covered
- Receive consulting fees, advisory payments, or equity stakes from companies in the categories it covers
When the publication does not have a paid link relationship with a product or platform covered in an analysis, this is noted in the analysis disclosure block.
Pre-Publication Review
Every analysis goes through the following review steps before publication:
- Source check: Every cited study, regulatory document, and price point is verified against the original source.
- Claim audit: Every benefit, efficacy, or outcome statement is checked against the evidence classification framework. Claims exceeding the evidence are revised.
- Compliance sweep: The analysis is reviewed against DSHEA, FTC, and category-specific regulatory requirements. This includes paid link disclosure placement, compounding medication disclosure where applicable, and removal of any language that could constitute a disease claim.
- Citation completeness: Every factual claim is traceable to a named source within the analysis or its references.
- Editorial accountability: The analysis is published under the HDC Health Intelligence Desk identity with the documented methodology backing it.
Updates and Revisions
Published analyses are reviewed periodically and updated when material information changes:
- Product-focused analyses are reviewed every 6 to 12 months
- Telehealth platform evaluations are re-verified quarterly for pricing and policy changes
- Ingredient research pages are updated when meaningful new studies are published
- Any analysis is updated promptly when a factual error is identified or when regulatory status changes
Updates involve substantive content revision, re-verification of sources, and an accurate “Last verified” or “Last updated” date — not a cosmetic date change.
Corrections Policy
The publication welcomes corrections. If a published analysis contains a factual error, misrepresented study finding, outdated regulatory information, or any other material inaccuracy, readers and other parties may submit a correction request through the Contact page. Select “Editorial Correction” as the inquiry type.
Correction requests are reviewed by the editorial team. Where a correction is warranted, the analysis is updated promptly, the change is documented in the analysis itself (the prior incorrect text is noted, the corrected text is supplied, and the date of correction is recorded), and the “Last updated” date is revised.
The publication does not silently edit content to remove errors without acknowledgment. Material corrections are documented within the affected analysis.
Reader Feedback
Readers who identify content gaps, suggest analyses, or want to flag concerns about an analysis are encouraged to use the Contact page. Feedback is reviewed by the editorial team and used to inform future content priorities, even where a specific correction is not warranted.
Editorial Independence Statement
HealthDataConsortium.org is a commercially funded independent publication. Its only revenue source is paid link commissions. No pharmaceutical company, supplement manufacturer, telehealth platform, government entity, or other external party has editorial authority over what is published, how analyses are scored, or what conclusions are reached. The HDC Health Intelligence Desk operates with full editorial independence within these documented standards.